Hydroxychloroquine dosing in systemic lupus erythematosus: response to 'Comment on the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis et al' by Costedoat-Chalumeau et al

doi:10.1136/annrheumdis-2019-215615

Comment

. 2020 Aug;79(8):e91.

doi: 10.1136/annrheumdis-2019-215615. Epub 2019 Jun 14.

Hydroxychloroquine dosing in systemic lupus erythematosus: response to 'Comment on the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis et al' by Costedoat-Chalumeau et al

Antonis Fanouriakis¹, George Bertsias^{2

3}, Dimitrios T Boumpas^{4

5

6}

Affiliations

¹ Rheumatology and Clinical Immunology, 4th Department of Internal Medicine, "Attikon" University Hospital, Athens, Greece.
² Department of Rheumatology, Clinical Immunology and Allergy, University Hospital of Heraklion, Heraklion, Greece.
³ Laboratory of Autoimmunity-Inflammation, Institute of Molecular Biology and Biotechnology, Heraklion, Greece.
⁴ Rheumatology and Clinical Immunology, 4th Department of Internal Medicine, "Attikon" University Hospital, Athens, Greece boumpasd@uoc.gr.
⁵ Laboratory of Autoimmunity and Inflammation, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
⁶ Joint Academic Rheumatology Program, Medical School, National and Kapodestrian University of Athens, Athens, Greece.

PMID: 31201171
DOI: 10.1136/annrheumdis-2019-215615

Comment

Hydroxychloroquine dosing in systemic lupus erythematosus: response to 'Comment on the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis et al' by Costedoat-Chalumeau et al

Antonis Fanouriakis et al. Ann Rheum Dis. 2020 Aug.

. 2020 Aug;79(8):e91.

doi: 10.1136/annrheumdis-2019-215615. Epub 2019 Jun 14.

Authors

Antonis Fanouriakis¹, George Bertsias^{2

3}, Dimitrios T Boumpas^{4

5

6}

Affiliations

¹ Rheumatology and Clinical Immunology, 4th Department of Internal Medicine, "Attikon" University Hospital, Athens, Greece.
² Department of Rheumatology, Clinical Immunology and Allergy, University Hospital of Heraklion, Heraklion, Greece.
³ Laboratory of Autoimmunity-Inflammation, Institute of Molecular Biology and Biotechnology, Heraklion, Greece.
⁴ Rheumatology and Clinical Immunology, 4th Department of Internal Medicine, "Attikon" University Hospital, Athens, Greece boumpasd@uoc.gr.
⁵ Laboratory of Autoimmunity and Inflammation, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
⁶ Joint Academic Rheumatology Program, Medical School, National and Kapodestrian University of Athens, Athens, Greece.

PMID: 31201171
DOI: 10.1136/annrheumdis-2019-215615

No abstract available

Keywords: DMARDs (synthetic); systemic lupus erythematosus; treatment.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment on

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.
Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, Cervera R, Doria A, Gordon C, Govoni M, Houssiau F, Jayne D, Kouloumas M, Kuhn A, Larsen JL, Lerstrøm K, Moroni G, Mosca M, Schneider M, Smolen JS, Svenungsson E, Tesar V, Tincani A, Troldborg A, van Vollenhoven R, Wenzel J, Bertsias G, Boumpas DT. Fanouriakis A, et al. Ann Rheum Dis. 2019 Jun;78(6):736-745. doi: 10.1136/annrheumdis-2019-215089. Epub 2019 Mar 29. Ann Rheum Dis. 2019. PMID: 30926722
Comment on the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis et al.
Costedoat-Chalumeau N, Isenberg D, Petri M. Costedoat-Chalumeau N, et al. Ann Rheum Dis. 2020 Aug;79(8):e90. doi: 10.1136/annrheumdis-2019-215573. Epub 2019 May 2. Ann Rheum Dis. 2020. PMID: 31048291 No abstract available.

Cited by

Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil.
Pileggi GS, Ferreira GA, Reis APMG, Reis-Neto ET, Abreu MM, Albuquerque CP, Araújo NC, Bacchiega AB, Bianchi DV, Bica B, Bonfa ED, Borba EF, Brito DCSE, Duarte ÂLBP, Santo RCE, Fernandes PR, Guimarães MP, Gomes KWP, Kakehasi AM, Klumb EM, Lanna CCD, Marques CDL, Monticielo OA, Mota LMH, Munhoz GA, Paiva ES, Pereira HLA, Provenza JR, Ribeiro SLE, Junior LFR, Sampaio CSJC, Sampaio VS, Sato EI, Skare T, de Souza VA, Valim V, Lacerda MVG, Xavier RM, Pinheiro MM. Pileggi GS, et al. Adv Rheumatol. 2021 Oct 7;61(1):60. doi: 10.1186/s42358-021-00217-0. Adv Rheumatol. 2021. PMID: 34620246 Free PMC article.
Coalition: Advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against COVID-19.
Picot S, Marty A, Bienvenu AL, Blumberg LH, Dupouy-Camet J, Carnevale P, Kano S, Jones MK, Daniel-Ribeiro CT, Mas-Coma S. Picot S, et al. One Health. 2020 Apr 4;9:100131. doi: 10.1016/j.onehlt.2020.100131. eCollection 2020 Jun. One Health. 2020. PMID: 32292817 Free PMC article.
Systemic lupus erythematosus: year in review 2019.
Fan Y, Hao YJ, Zhang ZL. Fan Y, et al. Chin Med J (Engl). 2020 Sep 20;133(18):2189-2196. doi: 10.1097/CM9.0000000000000983. Chin Med J (Engl). 2020. PMID: 32810049 Free PMC article. Review.
Health Care-Seeking Behaviors, Disease Progression, Medications, Knowledge of, and Attitudes Toward Systemic Lupus Erythematosus in China: Cross-sectional Survey Study.
Dai Z, Huang X, Yuan F, Li T, Xie B, Lin H, Yang P, Li X, Xu S, Zhao J, Wang Y, Peng X, Wei S, Huang W, Li J, Liang J, Liu X, Chu Y, Zhang Z, Zhang R, Lau EHY, Lin Z. Dai Z, et al. JMIR Public Health Surveill. 2023 Apr 7;9:e44541. doi: 10.2196/44541. JMIR Public Health Surveill. 2023. PMID: 37027203 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Hydroxychloroquine dosing in systemic lupus erythematosus: response to 'Comment on the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis et al' by Costedoat-Chalumeau et al

Affiliations

Hydroxychloroquine dosing in systemic lupus erythematosus: response to 'Comment on the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis et al' by Costedoat-Chalumeau et al

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Conflict of interest statement

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical